PR NEWSWIRE - Contenuti promozionali

immediapress comunicato stampa

Keymed Biosciences Announces 2026 H1 Results and Business Updates

CHENGDU, China, Aug. 21, 2026 /PRNewswire/ -- On August 19, 2026, Keymed Biosciences (HKEX: 02162) announced its interim results for the six months ended June 30, 2026, with total revenue of RMB617 million. Core product Kangyueda generated sales of RMB393 million, up 132% YoY, supported by a nearly 5...

immediapress comunicato stampa

NNS acquires shares in OCI

LIMASSOL, Cyprus, Aug. 19, 2026 /PRNewswire/ -- Reference is made to the press release of 24th June 2026 by NNS regarding the public announcement of the Offer. Pursuant to the provision of Section 5, paragraph 4 of the Decree, NNS hereby announces that it has conducted transactions in the shares of O...



SEGUICI SUI SOCIAL

threads whatsapp linkedin twitter youtube facebook instagram

ora in
Prima pagina
articoli
in Evidenza